Report cover image

Global Latisse (Bimatoprost) Market Growth 2025-2031

Publisher LP Information, Inc.
Published Jan 13, 2024
Length 103 Pages
SKU # LPI19482662

Description

Global Latisse (Bimatoprost) Market Growth 2025-2031


The global Latisse (Bimatoprost) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Bimatoprost (CAS 155206-00-1), also known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic structural analogs of prostaglandin. Bimatoprost, marketed by Allergan, is administered in both the ophthalmic solution and implant form. It has the ability to reduce ocular hypotension, proving effective in conditions such as ocular hypertension and glaucoma. Bimatoprost is also used to treat eyelash hypotrichosis, or sparse eyelash growth. It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug.

Global Latisse (Bimatoprost) (CAS 155206-00-1) key players include Chirogate International, Cayman Pharma, Zhejiang Ausun, Everlight Chemical, and Lianmin Biochemical etc. Global top three players hold a share about 40%. North America is the largest market, with a share about 90%.

LP Information, Inc. (LPI) ' newest research report, the “Latisse (Bimatoprost) Industry Forecast” looks at past sales and reviews total world Latisse (Bimatoprost) sales in 2024, providing a comprehensive analysis by region and market sector of projected Latisse (Bimatoprost) sales for 2025 through 2031. With Latisse (Bimatoprost) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Latisse (Bimatoprost) industry.

This Insight Report provides a comprehensive analysis of the global Latisse (Bimatoprost) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Latisse (Bimatoprost) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Latisse (Bimatoprost) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Latisse (Bimatoprost) and breaks down the forecast by Purity, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Latisse (Bimatoprost).

This report presents a comprehensive overview, market shares, and growth opportunities of Latisse (Bimatoprost) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Purity:
Below 99.5%
Other

Segmentation by Application:
Patented Product
General Products

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Cayman Pharma
Tecoland Corporation
TCS Group
Changzhou BOHIV
Zhejiang Ausun
Ansion Pharma
Lianmin Biochemical
Chirogate International
Everlight Chemical
GENTEC

Key Questions Addressed in this Report

What is the 10-year outlook for the global Latisse (Bimatoprost) market?

What factors are driving Latisse (Bimatoprost) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Latisse (Bimatoprost) market opportunities vary by end market size?

How does Latisse (Bimatoprost) break out by Purity, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

103 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Latisse (Bimatoprost) by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Latisse (Bimatoprost) by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us